FDA raps Bayer in combo' product crackdown (Nutraingredients.com)
The two combination products Bayer Heart Advantage (aspirin plus plant sterols) and Bayer Women's (aspirin plus calcium carbonate) sent a mixed message , the FDA wrote in warning letters to Bayer.

FDA Approves RiaSTAP For Treatment Of Bleeding In Patients With Rare Genetic Defect (Medical News Today)
The U.S. Food and Drug Administration licensed RiaSTAP, an orphan drug for the treatment of bleeding in patients with a rare genetic defect known as congenital fibrinogen deficiency. Without treatment, these patients are at risk of potentially life-threatening bleeding.